Manley Harold J, Cannella Carrie A, Bailie George R, St Peter Wendy L
Albany College of Pharmacy, Albany, NY 12208, USA.
Am J Kidney Dis. 2005 Oct;46(4):669-80. doi: 10.1053/j.ajkd.2005.07.001.
Medication-related problems are common in hemodialysis (HD) patients. These patients often require 12 medications to treat 5 to 6 comorbid conditions. Medication-related problem research reports cannot be generalized to the entire HD population because data are obtained from single centers and limited numbers of patients. We conducted a pooled analysis to gain additional insight into the frequency, type, and severity of medication-related problems and extrapolated the data to the entire US HD population.
Articles were identified through a MEDLINE search (1962 to March 2004). Seven studies were included in the analysis. Medication-related problems were categorized into the following 9 categories: indication without drug therapy, drug without indication, improper drug selection, subtherapeutic dosage, overdosage, adverse drug reaction, drug interaction, failure to receive drug, and inappropriate laboratory monitoring. A medication-related problem appearance rate was determined.
We identified 1,593 medication-related problems in 395 patients (51.2% men; age, 52.4 +/- 8.2 years; 42.7% with diabetes). The most common medication-related problems found were inappropriate laboratory monitoring (23.5%) and indication without drug therapy (16.9%). Dosing errors accounted for 20.4% of medication-related problems (subtherapeutic dosage, 11.2%; overdosage, 9.2%). The medication-related problem appearance rate was 5.75e(-0.37x), where x equals number of months of follow-up (P = 0.02).
HD patients experience ongoing medication-related problems. Reduction in medication-related problems in dialysis patients may improve quality of life and result in decreased morbidity and mortality. Pharmacists are uniquely trained to detect and manage medication-related problems. Pharmacists should be an integral member of the dialysis health care team.
与药物相关的问题在血液透析(HD)患者中很常见。这些患者通常需要12种药物来治疗5至6种合并症。与药物相关问题的研究报告不能推广到整个HD人群,因为数据是从单一中心和有限数量的患者中获得的。我们进行了一项汇总分析,以进一步了解与药物相关问题的频率、类型和严重程度,并将数据外推至整个美国HD人群。
通过MEDLINE搜索(1962年至2004年3月)确定文章。分析纳入了7项研究。与药物相关的问题分为以下9类:有适应证但未用药、用药无适应证、药物选择不当、治疗剂量不足、用药过量、药物不良反应、药物相互作用、未用药和实验室监测不当。确定了与药物相关问题的出现率。
我们在395例患者中发现了1593个与药物相关的问题(男性占51.2%;年龄52.4±8.2岁;42.7%患有糖尿病)。发现的最常见的与药物相关的问题是实验室监测不当(23.5%)和有适应证但未用药(16.9%)。给药错误占与药物相关问题的20.4%(治疗剂量不足占11.2%;用药过量占9.2%)。与药物相关问题的出现率为5.75e(-0.37x),其中x等于随访月数(P = 0.02)。
HD患者持续存在与药物相关的问题。减少透析患者与药物相关的问题可能会改善生活质量,并降低发病率和死亡率。药剂师经过专门培训,能够检测和处理与药物相关的问题。药剂师应成为透析医疗团队不可或缺的成员。